Alexander Spira, MD, PhD, discusses why sarcoma treatment lags other cancers, citing tumor heterogeneity and inconsistent immunotherapy response as barriers.
Alexander Spira, MD, PhD, FACP, FASCO
Advertisement
Articles by Alexander Spira, MD, PhD, FACP, FASCO
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Walcker Named President of Cardinal’s The Specialty Alliance, With Strengths in GI, Urology
2
FDA Approves Another OTC Naloxone Nasal Spray for Opioid Overdose
3
5 Questions Dermatology Patients May Have About Newly-Approved Bemotrizinol
4
Venetoclax-Obinutuzumab Tops Acalabrutinib in First-Line CLL
5